Cancer patients may want another specialist view before surgery, chemotherapy, radiotherapy, targeted therapy or immunotherapy decisions.

Families may need clearer interpretation of pathology, staging, scans and whether the current plan fits the diagnosis.

Some patients want to compare China-based oncology pathways when local or regional options feel limited.

Patients with recurrent, metastatic or difficult cancer may seek review of additional treatment directions.

Cancer decisions often involve family members who need clear, structured information before supporting travel.

Some patients ask about innovative drugs, devices or cell-related options, which require strict physician review.

Patients who want a second opinion before committing to their first major cancer treatment plan.

Patients whose cancer has returned and who want to review whether other options may be relevant.

Families considering Singapore, Malaysia, Thailand or China and needing a structured medical comparison.

Patients who may benefit from coordinated oncology, surgery, radiology, pathology and rehabilitation perspectives.

Patients with leukemia, lymphoma or myeloma seeking hematology review, transplant assessment or CAR-T eligibility discussion.

Patients interested in innovative cancer drugs or devices subject to indication, availability and approval. **Compliance Note:** Not every patient is suitable for medical travel or China-based care. A case review helps determine whether this solution may be appropriate.

China-based specialists may review diagnosis, staging, treatment history and possible next-step options based on submitted records.

Where appropriate, pathology slides, reports and imaging may be reviewed to clarify diagnosis and treatment direction.

A coordinated review may include oncology, surgery, imaging, pathology and rehabilitation perspectives for complex cancer decisions.

Specialists may evaluate whether biomarkers, prior treatment and disease stage support targeted or immunotherapy discussion.

For selected blood cancers, hematology teams may review transplant, CAR-T or other advanced therapy eligibility.

Selected innovative drug or device pathways may be explored subject to indication, eligibility, availability and hospital approval. - **CTA:** Request a China Medical Solution.

We collect the patient’s diagnosis, symptoms, treatment history, goals and key concerns before building the proposal.

We help identify the reports, imaging, pathology, lab tests and summaries needed for review.

Important documents may be translated or summarized to support China hospital communication.

We prepare a concise case summary to help relevant China medical resources understand the patient’s situation.

We match the case with suitable hospitals, departments or specialist pathways based on medical need.

Patients receive a case-based proposal outlining possible China medical directions and next-step coordination.

Where appropriate, we may coordinate a paid video consultation with a China-based medical expert.

After a travel decision, we may support appointment planning, interpretation, reports and follow-up documentation. **Boundary Statement:** medChina.global is not a hospital or treating provider. We coordinate solution proposals, communication, video consultations, and travel-related medical support. - **CTA:** Upload Your Medical Records.